The Latest Breaking News from Vaccine

Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a "single-minded focus on safety first." Read further on Dynamite News:

Moderna stock broke out for the first time in a year Thursday after beating first-quarter expectations as its second potential approval looms.

Much lower sales of Covid-19 vaccine Comirnaty and therapeutic Paxlovid accounted for a 20 percent drop in first-quarter revenues to $14.9 billion compared with the year-ago period.

Controversy over Covishield safety reaches Supreme Court, petition seeks expert panel to study risk factors and vaccine consequences.

“I’m not anti-vaccine,” the independent candidate told Maher. “I’m called that because it’s a way of silencing me”

More than 50% of the patients who used a new mouth-spray-based vaccine didn't have a UTI for up to nine years.

With nearly 5,000 cases reported so far this year — and concerns about a new strain — the Democratic Republic of Congo is considering the declaration of a public health emergency.

The mRNA vaccine being tested on melanoma patients has been described as one of the most exciting developments in cancer treatment for many years

Excitement among patients and researchers as custom-built jabs enter phase 3 trial

Human Rights Watch says 223 civilians were summarily executed by soldiers in a single day in Burkina Faso. Also, heavy rain continues to bring devastation in Kenya's capital Nairobi, with roads turned into rivers. And it's been a year since Ghana started using a new malaria vaccine. Children have received…

Malaria incidents are on the rise. There were 249 million cases of this parasitic disease in 2022, five million more than in 2021.